{"id":"https://openalex.org/W3205555899","doi":"https://doi.org/10.1177/20503121211050186","title":"Eptinezumab: A calcitonin gene-related peptide monoclonal antibody infusion for migraine prevention","display_name":"Eptinezumab: A calcitonin gene-related peptide monoclonal antibody infusion for migraine prevention","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3205555899","doi":"https://doi.org/10.1177/20503121211050186","mag":"3205555899","pmid":"https://pubmed.ncbi.nlm.nih.gov/34659764","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8511911"},"language":"en","primary_location":{"id":"doi:10.1177/20503121211050186","doi":"https://doi.org/10.1177/20503121211050186","is_oa":true,"landing_page_url":"https://doi.org/10.1177/20503121211050186","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/20503121211050186","source":{"id":"https://openalex.org/S2764485085","display_name":"SAGE Open Medicine","issn_l":"2050-3121","issn":["2050-3121"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SAGE Open Medicine","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/20503121211050186","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035197938","display_name":"Kelsey Woods Morgan","orcid":"https://orcid.org/0000-0002-2589-7454","observed_orcids":["https://orcid.org/0000-0002-2589-7454"]},"institutions":[{"id":"https://openalex.org/I200033832","display_name":"Shenandoah University","ror":"https://ror.org/05w0p9h92","country_code":"US","type":"education","lineage":["https://openalex.org/I200033832"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kelsey Woods Morgan","raw_affiliation_strings":["Department of Pharmacy Practice, Bernard J. Dunn School of Pharmacy, Shenandoah University, Winchester, VA, USA"],"raw_orcid":"https://orcid.org/0000-0002-2589-7454","affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, Bernard J. Dunn School of Pharmacy, Shenandoah University, Winchester, VA, USA","institution_ids":["https://openalex.org/I200033832"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048794741","display_name":"Kayla Rena Joyner","orcid":"https://orcid.org/0000-0003-2607-1459","observed_orcids":["https://orcid.org/0000-0003-2607-1459"]},"institutions":[{"id":"https://openalex.org/I200033832","display_name":"Shenandoah University","ror":"https://ror.org/05w0p9h92","country_code":"US","type":"education","lineage":["https://openalex.org/I200033832"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kayla Rena Joyner","raw_affiliation_strings":["Department of Pharmacy Practice, Bernard J. Dunn School of Pharmacy, Shenandoah University, Winchester, VA, USA"],"raw_orcid":"https://orcid.org/0000-0003-2607-1459","affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, Bernard J. Dunn School of Pharmacy, Shenandoah University, Winchester, VA, USA","institution_ids":["https://openalex.org/I200033832"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5035197938"],"corresponding_institution_ids":["https://openalex.org/I200033832"],"apc_list":{"value":1125,"currency":"USD","value_usd":1125},"apc_paid":{"value":1125,"currency":"USD","value_usd":1125},"fwci":0.1783,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.18627451,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"9","issue":null,"first_page":"20503121211050186","last_page":"20503121211050186"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10420","display_name":"Intracranial Aneurysms: Treatment and Complications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eptinezumab","display_name":"eptinezumab","score":1.0},{"id":"https://openalex.org/keywords/calcitonin-gene-related-peptide","display_name":"calcitonin gene-related peptide","score":0.8989999890327454},{"id":"https://openalex.org/keywords/anti-cgrp-monoclonal-antibodies","display_name":"CGRP monoclonal antibodies","score":0.9340000152587891},{"id":"https://openalex.org/keywords/migraine-prevention","display_name":"migraine prophylaxis","score":0.984000027179718},{"id":"https://openalex.org/keywords/episodic-migraine","display_name":"episodic migraine","score":0.8619999885559082},{"id":"https://openalex.org/keywords/chronic-migraine","display_name":"chronic migraine","score":1.0},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.753000020980835},{"id":"https://openalex.org/keywords/onset-of-action","display_name":"onset of action","score":0.6539999842643738},{"id":"https://openalex.org/keywords/refractory-migraine","display_name":"refractory migraine","score":0.7009999752044678},{"id":"https://openalex.org/keywords/fda-approval","display_name":"FDA approval","score":0.4169999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.936802089214325},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.8574320077896118},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7385976314544678},{"id":"https://openalex.org/C2910587157","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Chronic Migraine","level":3,"score":0.6690337657928467},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6543824076652527},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6092846393585205},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5877945423126221},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4846563935279846},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47073256969451904},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.4677845239639282},{"id":"https://openalex.org/C163170386","wikidata":"https://www.wikidata.org/wiki/Q419432","display_name":"Calcitonin gene-related peptide","level":4,"score":0.44276049733161926},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4107182025909424},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.22574132680892944},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08718898892402649},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C118303440","wikidata":"https://www.wikidata.org/wiki/Q419968","display_name":"Neuropeptide","level":3,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1177/20503121211050186","doi":"https://doi.org/10.1177/20503121211050186","is_oa":true,"landing_page_url":"https://doi.org/10.1177/20503121211050186","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/20503121211050186","source":{"id":"https://openalex.org/S2764485085","display_name":"SAGE Open Medicine","issn_l":"2050-3121","issn":["2050-3121"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SAGE Open Medicine","raw_type":"journal-article"},{"id":"pmid:34659764","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34659764","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SAGE open medicine","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8511911","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8511911/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SAGE Open Med","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:76457cda0a3e4d078789c7e01855ed86","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/76457cda0a3e4d078789c7e01855ed86","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"SAGE Open Medicine, Vol 9 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1177/20503121211050186","doi":"https://doi.org/10.1177/20503121211050186","is_oa":true,"landing_page_url":"https://doi.org/10.1177/20503121211050186","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/20503121211050186","source":{"id":"https://openalex.org/S2764485085","display_name":"SAGE Open Medicine","issn_l":"2050-3121","issn":["2050-3121"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SAGE Open Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3205555899.pdf"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W73775937","https://openalex.org/W2001650386","https://openalex.org/W2047455969","https://openalex.org/W2086228377","https://openalex.org/W2118912931","https://openalex.org/W2127042724","https://openalex.org/W2136324281","https://openalex.org/W2148445312","https://openalex.org/W2549116677","https://openalex.org/W2754967293","https://openalex.org/W2763655322","https://openalex.org/W2791018156","https://openalex.org/W2801085490","https://openalex.org/W2801341258","https://openalex.org/W2888026698","https://openalex.org/W2893863004","https://openalex.org/W2947910421","https://openalex.org/W2955283194","https://openalex.org/W2955317067","https://openalex.org/W2986364716","https://openalex.org/W3007053288","https://openalex.org/W3012537592","https://openalex.org/W3013502865","https://openalex.org/W3014490536","https://openalex.org/W3023532405","https://openalex.org/W3092275911","https://openalex.org/W3099375191","https://openalex.org/W3108476696","https://openalex.org/W3111843559","https://openalex.org/W3138531994","https://openalex.org/W3143605886","https://openalex.org/W3157419554","https://openalex.org/W3167806128","https://openalex.org/W4389441188","https://openalex.org/W4389441380","https://openalex.org/W4389442214"],"related_works":["https://openalex.org/W3013502865","https://openalex.org/W4392584080","https://openalex.org/W4283794549","https://openalex.org/W3007053288","https://openalex.org/W2955283194","https://openalex.org/W2805739889","https://openalex.org/W3099375191","https://openalex.org/W4312244046","https://openalex.org/W4389441380","https://openalex.org/W3092275911"],"abstract_inverted_index":{"This":[0],"article":[1],"seeks":[2],"to":[3,13,20,110,127,144,151,203,240],"analyze":[4],"the":[5,9,68,159,163,196,219,251],"clinical":[6,22],"trials":[7,73],"concerning":[8],"newly":[10],"approved":[11],"eptinezumab":[12,78,81,95,115,133,228],"assess":[14],"its":[15],"efficacy,":[16],"safety,":[17],"and":[18,36,47,58,65,84,88,162,181,183,255],"application":[19],"current":[21],"practice.":[23],"The":[24,165,173],"Institute":[25],"of":[26,31,77,100,189,233,258],"Health":[27],"US":[28],"National":[29],"Library":[30,38],"Medicine":[32],"Clinical":[33],"Trials,":[34],"PubMed,":[35],"Cochrane":[37],"databases":[39],"were":[40,63,179],"searched":[41],"for":[42],"relevant":[43],"abstracts,":[44],"journal":[45],"articles,":[46],"other":[48,220],"published":[49],"sources.":[50],"Search":[51],"terms":[52],"included":[53,66],"eptinezumab,":[54],"Vyepti":[55],"\u00ae":[56],",":[57],"ALD403.":[59],"Relevant":[60],"English-language":[61],"articles":[62],"evaluated":[64],"in":[67,86,97,139,147,222],"narrative.":[69],"Two":[70],"randomized":[71],"controlled":[72],"compared":[74,109,126,143],"quarterly":[75,213],"infusions":[76],"100":[79],"mg,":[80,83],"300":[82],"placebo":[85],"chronic":[87,113,248],"episodic":[89,93,246],"migraine":[90,104,118,141],"sufferers.":[91],"In":[92,112],"migraine,":[94,114],"resulted":[96],"a":[98,148,186,212,230],"reduction":[99,138],"approximately":[101,121],"4":[102],"monthly":[103,117,140],"days,":[105,123],"which":[106],"was":[107,168,185],"significant":[108,125],"placebo.":[111,128],"reduced":[116],"days":[119,142],"by":[120],"8":[122],"also":[124],"More":[129],"patients":[130],"who":[131],"received":[132],"experienced":[134],"at":[135],"least":[136],"75%":[137],"placebo,":[145],"resulting":[146],"number":[149],"needed":[150],"treat":[152],"as":[153,155,211],"low":[154,187],"6,":[156],"depending":[157],"on":[158],"study":[160,192],"population":[161],"dose.":[164],"preventive":[166],"impact":[167],"noticed":[169],"day":[170],"one":[171],"post-infusion.":[172],"most":[174],"common":[175],"treatment-emergent":[176],"adverse":[177],"events":[178],"nausea":[180],"fatigue,":[182],"there":[184],"incidence":[188],"hypersensitivity":[190],"or":[191,244,247],"withdrawal.":[193],"Eptinezumab":[194],"is":[195],"fourth":[197],"Calcitonin":[198],"Gene-related":[199],"Peptide":[200],"monoclonal":[201],"antibody":[202],"receive":[204],"Federal":[205],"Drug":[206],"Administration":[207],"approval.":[208],"Its":[209],"delivery":[210],"infusion":[214],"sets":[215],"it":[216],"apart":[217],"from":[218],"agents":[221],"this":[223],"class.":[224],"As":[225],"an":[226,259],"infusion,":[227],"has":[229],"quick":[231],"onset":[232],"action":[234],"that":[235],"may":[236],"prove":[237],"especially":[238],"beneficial":[239],"those":[241],"with":[242],"severe":[243],"refractory":[245],"migraines,":[249],"despite":[250],"perceived":[252],"increased":[253],"direct":[254],"indirect":[256],"cost":[257],"infusion.":[260]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-10-25T00:00:00"}